Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: AIDS. 2021 Sep 2:10.1097/QAD.0000000000003062. doi: 10.1097/QAD.0000000000003062

Table 1.

Baseline clinical and demographic characteristics

F/TAF (N=35) F/TDF (N=44)
Dosing breakdown (n) 33% (23), 67% (23), 100% (23) 33% (15), 67% (16), 100% (32)

Male at birth, n (%) 18 (51.4%) 21 (47.7%)

Race
Caucasian 29 (82.9%) 25 (56.8%)
Black 5 (14.3%) 8 (18.2%)
Asian 0 (0%) 3 (6.8%)
Native Hawaiian 0 (0%) 1 (2.3%)
Unknown 1 (2.9%) 7 (15.9%)

Hispanic 6 (17.1%) 12 (27.3%)

Age (years) 29 (18, 41) 29 (21, 49)

Weight (kg) 72.8 (45.9, 118.2) 75.4 (51.2, 155.3)

CrCl (mL/min) 120.3 (85.9, 243.7) 121.4 (77.6, 256.6)

All values expressed as n (%) or median (range). CrCl = Creatinine clearance, calculated using Cockcroft-Gault equation and actual body weight.